Home/Filings/4/0001209191-21-008568
4//SEC Filing

Engelson Erik T. 4

Accession 0001209191-21-008568

CIK 0001652724other

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 5:33 PM ET

Size

5.4 KB

Accession

0001209191-21-008568

Insider Transaction Report

Form 4
Period: 2021-02-04
Engelson Erik T.
DirectorPresident and Chief Executive
Transactions
  • Award

    Stock Option (right to buy)

    2021-02-04+173,937173,937 total
    Exercise: $17.00Exp: 2031-02-03Common Stock (173,937 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying this option shall vest on the first annual anniversary of the grant date and 1/48th of the shares underlying this option shall vest monthly thereafter over 36 months.

Issuer

Lucira Health, Inc.

CIK 0001652724

Entity typeother

Related Parties

1
  • filerCIK 0001839384

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 5:33 PM ET
Size
5.4 KB